A combination of resveratrol and cisplatin synergistically inhibited the MDA‐MB‐231 breast cancer cell viability and also inhibited TGF‐β1‐induced migration and invasion of MDA‐MB‐231cells by inhibiting EMT. The gene discussed is TGFB1; the disease is breast carcinoma.